Literature DB >> 9525271

Human microsomal epoxide hydrolase: 5'-flanking region genetic polymorphisms.

S Raaka1, C Hassett, C J Omiencinski.   

Abstract

Microsomal epoxide hydrolase (mEH) catalyses the hydrolysis of xenobiotic epoxides, including various epoxide derivatives of the procarcinogenic polyaromatic hydrocarbons. Levels of mEH enzymatic activity among different cell types and between individuals within the population vary considerably. Genetic polymorphisms within the structural region of the human mEH gene exist and appear to contribute to the population variance in functional expression. In this study, we used single strand conformational polymorphism analysis and direct DNA sequencing approaches to identify seven additional polymorphic sites within the upstream region of the mEH gene, spanning -743 to +185 bp, relative to the transcription initiation site. Allelic frequencies and linkages of the polymorphic nucleotides were determined in 51 individuals using restriction fragment length polymorphism or competitive oligonucleotide priming assays. To determine the functional significance of the individual nucleotide substitutions, DNA fragments representing the variant alleles were cloned into the heterologous pBRAMScat2 reporter vector, transfected into HepG2 cells and assessed for reporter gene expression. Results indicated that certain of these polymorphic loci might differentially regulate transcription, with the maximum contribution of any of the variants modifying levels of reporter gene activity by approximately 30%. These observations establish that genetic variation in the 5' flanking sequence of mEH gene is likely an additional contributing factor to the range of functional mEH expression existing in human populations.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9525271     DOI: 10.1093/carcin/19.3.387

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  12 in total

1.  Variability in human sensitivity to 1,3-butadiene: influence of polymorphisms in the 5'-flanking region of the microsomal epoxide hydrolase gene (EPHX1).

Authors:  Sherif Z Abdel-Rahman; Marinel M Ammenheuser; Curtis J Omiecinski; Jeffrey K Wickliffe; Judah I Rosenblatt; Jonathan B Ward
Journal:  Toxicol Sci       Date:  2005-02-16       Impact factor: 4.849

2.  Try113His and His139Arg polymorphisms in the microsomal epoxide hydrolase gene are not associated with risk of breast cancer.

Authors:  Wen-Feng Gong; Wen He; Qiu-Ming Zhang; Bang-De Xiang; Liang Ma; Shan Huang; Tao Bai; Jian-Hong Zhong; Le-Qun Li
Journal:  Tumour Biol       Date:  2014-05-20

3.  Variation in genes relevant to aromatic hydrocarbon metabolism and the risk of adult brain tumors.

Authors:  Anneclaire J De Roos; Nathaniel Rothman; Merideth Brown; Douglas A Bell; Gary S Pittman; William R Shapiro; Robert G Selker; Howard A Fine; Peter M Black; Peter D Inskip
Journal:  Neuro Oncol       Date:  2006-01-27       Impact factor: 12.300

4.  Functional analysis of human microsomal epoxide hydrolase genetic variants.

Authors:  Vinayak P Hosagrahara; Allan E Rettie; Christopher Hassett; Curtis J Omiecinski
Journal:  Chem Biol Interact       Date:  2004-11-20       Impact factor: 5.192

5.  The expression of human microsomal epoxide hydrolase is predominantly driven by a genetically polymorphic far upstream promoter.

Authors:  Xi Yang; Shun-Hsin Liang; Denise M Weyant; Philip Lazarus; Carla J Gallagher; Curtis J Omiecinski
Journal:  J Pharmacol Exp Ther       Date:  2009-04-13       Impact factor: 4.030

6.  Expression of a novel mRNA transcript for human microsomal epoxide hydrolase (EPHX1) is regulated by short open reading frames within its 5'-untranslated region.

Authors:  Hong Loan Nguyen; Xi Yang; Curtis J Omiecinski
Journal:  RNA       Date:  2013-04-05       Impact factor: 4.942

Review 7.  Polymorphisms of xenobiotic-metabolizing enzymes and susceptibility to cancer.

Authors:  A Hirvonen
Journal:  Environ Health Perspect       Date:  1999-02       Impact factor: 9.031

Review 8.  The genetics of chronic obstructive pulmonary disease.

Authors:  Alice M Wood; Robert A Stockley
Journal:  Respir Res       Date:  2006-10-20

9.  Phase I metabolic genes and risk of lung cancer: multiple polymorphisms and mRNA expression.

Authors:  Melissa Rotunno; Kai Yu; Jay H Lubin; Dario Consonni; Angela C Pesatori; Alisa M Goldstein; Lynn R Goldin; Sholom Wacholder; Robert Welch; Laurie Burdette; Stephen J Chanock; Pier Alberto Bertazzi; Margaret A Tucker; Neil E Caporaso; Nilanjan Chatterjee; Andrew W Bergen; Maria Teresa Landi
Journal:  PLoS One       Date:  2009-05-21       Impact factor: 3.240

10.  Xenobiotic metabolizing enzyme gene polymorphisms predict response to lung volume reduction surgery.

Authors:  Craig P Hersh; Dawn L DeMeo; John J Reilly; Edwin K Silverman
Journal:  Respir Res       Date:  2007-08-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.